Guthrie Organization | Donald Guthrie Foundation - Sayre

Research site

Location

One Guthrie Square, Sayre, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

Aspirin

Gemcitabine

Docetaxel

ONC-392

Vinflunine

Balsalazide Disodium

Cisplatin

Prasugrel

CT-2103

Brazikumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

4 of 31 total trials

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation (LIBREXIA-AF)

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non-cent...

Enrolling

Atrial Fibrillation

Drug: Apixaban Placebo

Drug: Milvexian

Aveir DR i2i Study

Prospective, non-randomized, multi-center, international study designed to evaluate the safety and effectiveness of the Aveir™ Dual-Chamber (DR) Lead...

Active, not recruiting

Bradycardia

Cardiac Rhythm Disorder

Device: Aveir DR Leadless Pacemaker System

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors (PRESERVE-003)

The goal of this Phase 3 clinical trial is study the safety and efficacy of the nextgen anti-CTLA-4 antibody, gotistobart (ONC-392/BNT316), in patien...

Enrolling

Non Small Cell Lung Cancer

Drug: Gotistobart

Drug: Docetaxel

SMR Stemless Reverse Vs SMR Reverse Shoulder System

The SMR Stemless Reverse is intended for total, primary shoulder joint replacement by reducing pain and restoring shoulder articular mobility functio...

Enrolling

Arthroplasty, Replacement

Device: Investigational Arm: SMR Stemless Reverse

Device: Control Arm: SMR Reverse Shoulder System